ER-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with ER-Positive Breast Cancer — Part 4

Featuring perspectives from Dr Ruth O’Regan, including the following topics: Introduction (0:00) Case: A woman in her late 40s with an ER/PR-positive, HER2-negative, node-negative invasive ductal carcinoma (IDC) — Laila Agrawal, MD (5:09) Case: A woman in her mid-40s with ER/PR-positive, HER2-negative mBC — Raman Sood, MD (22:39) Case: A woman in her early 40s with ER/PR-positive, HER2-negative oligometastatic breast cancer — Arielle Heeke, MD (32:08) Case: A woman in her early 60s with ER/PR-positive, HER2-negative mBC with a PIK3CA mutation — Andrea Stebel, MD (35:31) Case: A postmenopausal woman in her early 50s with Stage IIIB ER/PR-positive, HER2-negative, node-positive breast cancer — Shaachi Gupta, MD, MPH (51:29) Case: A woman in her late 30s with ER/PR-positive, HER2-negative, node-positive IDC with a germline BRCA1 mutation — Dr Agrawal (57:02) CME information and select publications